A Lifetime of Working to Improve Outcomes in Multiple Myeloma

Abstract

Steve Schey speaks to Roshaine Gunawardana, Managing Commissioning Editor: Professor Stephen Schey is Consultant Haematologist and Honorary Senior Lecturer at King’s College Hospital and King’s College School of Medicine, King’s College London (London, UK). Schey qualified at St George’s Hospital (London, UK) in 1974, and later travelled to Australia where he worked at the Institute of Clinical Pathology and Medical Research in Sydney as Clinical Lecturer in Haematology. Subsequently, he returned to London to work at the Royal Free Hospital as Transplant Co-ordinator before working at the Royal Marsden (London, UK) and later the Middlesex Hospital (London, UK). Schey took up a Senior Lecturer post in 1985 and subsequently served as Director of Clinical Haematology for the Guy’s and St Thomas’ National Health Service (NHS) Foundation Trust from 1993 to 2004. Schey has contributed his services to a number of national and international professional bodies. He was chair of the UK Myeloma Forum from 2003 to 2009, following two terms as the Secretary from 1997. This was a productive period during which Schey managed the development of guidelines, clinical trials and advocacy for the UK Myeloma Forum patients and healthcare professionals. He has been Clinical Research Lead for the South East London Cancer Network since 2005. He also served on the National Cancer Research Institute (NCRI) Haemoncology Cancer Steering Group between 2002 and 2010, the NCRI Industry Adoption Panel and was Chairman of the NCRI Myeloma Clinical Trials Committee until 2010. Schey was a member of the American Society for Hematology (ASH) Scientific Committee for Immunosecretory Disorders. He is currently the Professor of Plasma Cell Dyscrasias at King’s College London.